Dr Agarwals Health Care Share Price: Apollo Hospital's New Rival Lists Flat On NSE, Should Investors Buy?

Dr Agarwals Health Care Share Price: After tepid demand in IPO, Dr Agarwals listed at a slight discount on BSE and NSE compared to its issue price of Rs 402. The stock which is competing against giants like Apollo Hospital, is trading on a bearish note. Expert has advised non-allotted investors to wait and watch for better pricing in Dr Agarwals share price.

Dr Agarwals Health Care Share Price BSE:

On BSE, Dr Agawals' share price with the initial of AGARWALE listed at Rs 396.90 apiece, which was at a 1.3% discount from its IPO issue price of Rs 402. The stock has touched a new 52-week high and low of Rs 412.75 apiece and Rs 370.10 apiece on its debut.

Currently, the market cap is around Rs 12,504.10 crore. The stock traded at Rs 395.85 apiece, marginally lower from the listing price, but down by 1.5% from the IPO price. The stock is listed under the B category.

Dr Agarwals Healthcare Care Share Price NSE:

However, unlike BSE, Dr Agarwals' share price opened flat at Rs 402 on NSE, which is the same as its IPO issue price. The stock touched a new 52-week high and low of Rs 412.90 apiece and Rs 370.20 apiece here as well. The stock was corrected after its opening bell.

At the time of writing, Dr Agarwals traded at Rs 400.50 apiece, down by 0.4% from the listing price. The market cap is around Rs 12,650.99 crore.

What Should Investors Do?

Prashanth Tapse, Senior VP (Research), Mehta Equities said, that despite markets in a recovering mood, Dr Agarwal's eye listing was in line with our expectations with the neutral and negative opening. The offer received modest subscription demand from all investors except QIB while other categories like NII, retail and employee quota were subscribed below 1x. The listing is justified on the back of 90% of the offer leaving less value for investors on the table.

Tapse added, considering the market mood, we recommend allotted investors to continue holding it for the long term despite knowing that post-listing will invite short-term volatility, hence advice for non-allotted investors, to wait and watch for better pricing.

The IPO opened on January 29 and closed on January 31, 2025. The 100% book building had a price band of Rs 382 to Rs 402 per equity share, with a face value of Re 1 each. On the final day of the IPO, it was subscribed b.55 times, mainly driven by qualified institutional buyers (QIBs), whose portion oversubscribed by 4.64 times. The portion of non-institutional investors (NII) and retail individual investors (RII) did not receive the full subscription.

Dr Agarwals Healthcare provides a comprehensive range of eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sells opticals, contact lenses and accessories, and eye care-related pharmaceutical products. The company had a market share of approximately 25% of the total eye care service chain market in India during the Financial Year 2024